Many signaling pathways have been proposed to be dysregulated in Alzheimer's disease, including WNT, TGFβ, p53, mTOR, NFkB, and Pi3k/Akt signaling. The gene discussed is TGFB1; the disease is early-onset autosomal dominant Alzheimer disease.